CRP and metabolic syndrome: The present study demonstrated that: (1) T-LTPA was dose-dependently associated with BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HDL cholesterol, HS-CRP, and prevalence of metabolic syndrome; (2) T-LTPA was inversely associated with HbA1c in non-obese participants but not in obese participants after multivariate adjustment; (3) higher-intensity LTPA (≥3.6 METs) was associated with HbA1c and HOMA2-IR, whereas lower-intensity LTPA was not.